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ABSTRACT
Background: Recently brain natriuretic peptide (BNP) level has been introduced as a 
screening test for congestive heart failure (CHF) in children. The current CHF assessment 
scores are not satisfactory as they use a large number of variables.
Objective: To evaluate two CHF scores: a modified clinical score and an echo-
cardiographic score and compare them to BNP in paediatric patients.
Design: Prospective, hospital based study.
Setting: Two paediatric cardiac referral centres in Khartoum from April to July 2010.
Subjects: All patients one month to 18 years of age with the clinical diagnosis of CHF 
were included. 
Results: Sixty seven patients were enrolled, 39 (58%) had congenital heart disease 
(CHD), 27 (32%) had rheumatic heart disease (RHD), and seven (10%) had dilated 
cardiomyopathy (DCM).Twenty four younger children (88%) and 29 older children 
(85%) had a high clinical score (severe CHF). Twenty one out of 23 younger children 
with high echo score (91%) had a high clinical score as well (p-value 0.001). In patients 
with RHD (all with a high clinical score), 81 % had a high echo score. (p-value 0.001). 
All younger children with a high clinical score (n=24) had a high level of BNP (p-value 
0.00). In older children with a high clinical score 28 out of 29 (96%) had a high BNP level 
(p-value 0.00). Of patients with RHD and a high echo score (21), 16 (76.2%) patients 
had high BNP level and five (23.8%) had low level of BNP. All patients with DCM had 
high echo score and all of them had high levels of BNP (100%) (p-value.0.00). 
Conclusion: We tested clinical and echo scores and proved their value in assessment 
of CHF in children. The scores correlated well with BNP level. We recommend the 
use of these scores as well as BNP level in clinical practice.
INTRODUCTION
Congestive heart failure (CHF) is an important 
problem in the paediatric age. Historically, the 
diagnosis of CHF depends on clinical and chest X 
ray findings; however there are many limitations 
to these methods especially in the young infants 
where many diseases can simulate CHF. The current 
CHF assessment scores are not satisfactory as they 
use a large number of variables (1). Recently brain 
natriuretic peptide (BNP) level has been introduced 
as a reliable screening test for CHF in children (2). In 
this study we evaluated   two CHF scores: a modified 
clinical score and an echo-cardiographic score and 
compared them with BNP in paediatric patients.
MATERIALS AND METHODS
The study was prospective, cross sectional, hospital 
based carried at two paediatric cardiac referral centres 
in Khartoum from April to July 2010.All patients one 
month to 18 years of age with the clinical diagnosis of 
CHF were included. Patients with major extra-cardiac 
diseases were excluded. Patients were divided into 
two age groups: younger children (one month to two 
years) and older children (2-18 years).History, cardio-
vascular examination, echo-cardiography and blood 
BNP were done and a data sheet was filled.
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1. A clinical score was designed that consists of 
the heart rate, respiratory rate, liver size and 
degree of growth failure in younger children 
(mild, moderate and severe growth failure 
are defined as weight for age below one, two 
and three standard deviations below the mean 
respectively) . For older children, the degree 
of growth failure was replaced with exercise 
intolerance (Table 1). According to these variables 
the maximum score is 12. Patients with scores 
more than six are considered to have severe CHF.
Table 1
 Clinical score: (out of 12)
 A: Age: 1-24/12
     Score
Sign 1 2 3
Heart rate <120 120-140 >140
Respiratory rate <40 40-60 >60
Liver span <4 cm 4-6 cm >6 cm
Growth failure Mild Moderate Severe
 B: Age: >24/12-18 y
Score
Sign 1 2 3
Heart rate <100 100-120 >120
Respiratory rate <20 20-30 >30
Liver span <6 cm 6-8 cm >8 cm
Exercise Intolerance On severe exertion On mild exertion At rest
2. Echo-cardiographic (echo) scores were designed according to the type of cardiac disease (Table2). 
 The maximum score is six. A score of four or more is considered high. LV(d) scores were derived from 
those published by Lipshultz et al (3)
Table 2
Echo-cardiographic Scores: (out of 6)
2-A: Valvular Heart Disease echo score
 Score
Echo finding 1 2
Valve lesion echo severity Moderate Severe
Pulmonary hypertension
(% of pulmonary to systemic 
blood pressure)
50- 75% >75%
LV (d) Z score 1-3 >3
2-B: CHD Echo score 
 Score
Echo finding 1 2
Size of the defect (VSD/PDA) 3 mm or less >3 mm
Doppler gradient (mmHg) 40-60 <40
LV (d) Z score 1-3 >3
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C: DCM Echo score
 Score
Echo finding 2 3
Ejection fraction (%) 30-55 <30
LV (d) Z score 1-3 >3
Table 3
The correlation of clinical score with echocardiographic score in younger children with CHD
 Clinical score
Echo score High (%) Low (%) Total (%)
    High 21 (65.6) 2 (6.2) 23 (71.9)
    Low 2 (6.3) 7 (21.9) 9 (28.1)
    Total 23 (71.9) 9 (28.1) 32 (100.0)
 I. For congenital heart disease (CHD) the score 
consists of:
  i. The size of the defect.
  ii. Doppler gradient across the defect.
  iii. The left ventricle diastolic dimension 
(LVd) Z-score.
  Complex congenital heart disease and 
complete atrio-ventricular septal defect 
(AVSD) are considered to have a high score. 
Partial AVSD is evaluated according to the 
valve regurgitation (Table 2-B)
 II. For valvular heart disease the score consists 
of:
  i. The echo severity of the valvular lesion.
  ii. Pulmonary hypertension (PHTN).
  iii. LV(d) Z-score
  Combined moderate lesions are given a high 
score. 
 III. For dilated cardiomyopathy (DCM) the score 
consists of:
  i. Ejection fraction (EF)
  ii. LV (d) Z-score
3. Blood level of BNP was done for all patients. A 
qualitative method was used where a level above 
200 nanogram/ml is considered significant.
RESULTS
The study included 67 children, 33 of them (49%) were 
in the age group one month to two years (younger 
children), while 34 (51%) were older than two years 
(older children).
Diagnosis: Of 67 patients,  39 (58%) had CHD. The most 
common lesion was ventricular septal defect (VSD) 
(56%). Twenty one patients (32%) had  rheumatic 
heart disease (RHD), the most common lesion was 
combined mitral and aortic regurgitation (47%). 
DCM was diagnosed in seven patients (10%).
Clinical and echo scores: Twenty four younger children 
(88%) and 29 older children (85%) have a high clinical 
score (severe CHF). Of the 39 patients with CHD, 29 
had a high echo score, while all the patients with RHD 
and DCM had a high echo score.  Twenty one out of 
23 younger children with high echo score (91%) had 
a high clinical score as well (p-value 0.001) (Table 3) 
In patients with RHD (all with a high clinical score), 
81 % had a high echo score (p-value 0.001).  
Correlation between BNP level with clinical and echo 
scores:  All younger children with a high clinical score 
(n=24) had a high level of BNP (p-value 0.00) (Table 
4). In older children with a high clinical score 28 out 
of 29 (96%) had a high BNP level (p-value 0.00). Of 
the 29 patients with CHD and a high echo score, 
27 (93%) had a high level of BNP, while  in the ten 
patients who had a low echo-score, two had high 
level of BNP and eight had low level of BNP,  p-value 
0.00 (Table 5). Of patients with RHD and a high echo 
score (21), 16 (76.2%) patients had high BNP level 
and five (23.8%) had low level of BNP. All patients 
with DCM in this study had high echo-cardiographic 
score and all of them had high levels of BNP (100%) 
P-value 0.00.
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Table 4
The correlation of clinical score and BNP level in younger children
BNP
Positive (%) negative (%) Total (%)
Clinical score High 24 (72.2) 0 (0) 24 (72.7)
Low 0 (0) 9 (27.3) 9 (27.3)
Total 24 (72.7) 9 (27.3) 33 (100.0)
Table 5
The correlation of CHD echo score and BNP level  
BNP level
Positive (%) Negative (%) Total (%)
CHD-echo score High 21 (69.2) 2 (5.1) 29 (74.4)
Low 2 (5.1) 8 (20.5) 10 (25.6)
Total 29 (74.4) 10 (25.6) 39 (100.0)
DISCUSSION
BNP is now coming up as a routine screening test for 
CHF in paediatric and adult patients as the evidence 
from the current literature is rapidly accumulating 
(4,5). The diagnosis of CHF can be challenging 
especially in young children where common problems 
like pneumonia and bronchiolitis can have similar 
clinical pictures. Therefore, BNP can have a valuable 
role in the acute care setting (6). Grading the severity 
of CHF is important for clinical as well as research 
purposes. The previous clinical scores used in infants 
like Ross score included up to ten variables, therefore 
they were not frequently used in clinical practice. 
Research in the field of paediatric CHF is often limited 
because of the lack of reliable and practical CHF score. 
In this study we used a simplified score which proved 
to have a good correlation with the BNP level.  We 
also tested an echo score which, to our knowledge, 
has not been previously used. This echo score proved 
to have a good correlation with clinical scores as well 
as BNP level.  This finding supports the validity of 
the proposed clinical and echo scores especially in 
young children.  This correlation was not found in 
older patients with CHD, most likely because in this 
age group the severity of the clinical signs decreased 
due to the development of pulmonary vascular 
obstructive disease (Eisenmenger’s syndrome), 
however, the value of this test in older children is less 
than in infants as clinical diagnosis is usually reliable.
 There was a strong correlation between clinical 
and echo-cardiographic severity of patients with 
RHD with BNP level in our patients which was also 
found by  Ribeiro et al.(7). 
 In conclusion we tested clinical and echo scores 
and validated their value in evaluation of CHF in 
children. The scores correlated well with BNP level. 
We recommend the use of these scores as well as BNP 
level in clinical practice.
Limitations: the BNP level was done using qualitative 
rather than quantitative methods therefore the actual 
levels in patients with different scores could not be 
assessed.
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